CIPRALEX -10MG DIN 02263238
Status: Marketed
Holder: LUNDBECK CANADA INC
Molecule: ESCITALOPRAM (ESCITALOPRAM OXALATE)
Available to quote
Health Canada record
| Active ingredient(s) | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06AB10 ESCITALOPRAM |
| Original market date | 14-Feb-2005 |
| Current status date | 14-Feb-2005 |
| Source | Health Canada DPD |
Establishment licence of the holder
Lundbeck Canada Inc — licence 100814, currently licensed, last inspection rating C (2023-04-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ESCITALOPRAM (ESCITALOPRAM OXALATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02434652 | ACH-ESCITALOPRAM | ACCORD HEALTHCARE INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02434660 | ACH-ESCITALOPRAM | ACCORD HEALTHCARE INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02295024 | APO-ESCITALOPRAM | APOTEX INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02295016 | APO-ESCITALOPRAM | APOTEX INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02397358 | AURO-ESCITALOPRAM | AURO PHARMA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02397374 | AURO-ESCITALOPRAM | AURO PHARMA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02397366 | AURO-ESCITALOPRAM | AURO PHARMA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 15 MG | Approved |
| 02397331 | AURO-ESCITALOPRAM | AURO PHARMA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 5 MG | Approved |
| 02263211 | CIPRALEX -5MG | LUNDBECK CANADA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 5 MG | Approved |
| 02263246 | CIPRALEX -15MG | LUNDBECK CANADA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 15 MG | Approved |
| 02263254 | CIPRALEX -20MG | LUNDBECK CANADA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02429039 | ESCITALOPRAM | SIVEM PHARMACEUTICALS ULC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02424401 | ESCITALOPRAM | PRO DOC LIMITEE | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02424428 | ESCITALOPRAM | PRO DOC LIMITEE | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02429047 | ESCITALOPRAM | SIVEM PHARMACEUTICALS ULC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02429780 | ESCITALOPRAM | JAMP PHARMA CORPORATION | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02429799 | ESCITALOPRAM | JAMP PHARMA CORPORATION | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02430118 | ESCITALOPRAM | SANIS HEALTH INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02430126 | ESCITALOPRAM | SANIS HEALTH INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02466058 | ESCITALOPRAM | JUBILANT GENERICS LIMITED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Approved |
| 02466066 | ESCITALOPRAM | JUBILANT GENERICS LIMITED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Approved |
| 02421879 | IPG-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 5 MG | Approved |
| 02421909 | IPG-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Approved |
| 02421895 | IPG-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 15 MG | Approved |
| 02421887 | IPG-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Approved |
| 02423502 | MAR-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02423472 | MAR-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 5 MG | Approved |
| 02423480 | MAR-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02423499 | MAR-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 15 MG | Approved |
| 02407426 | MINT-ESCITALOPRAM | MINT PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 15 MG | Approved |
| 02407434 | MINT-ESCITALOPRAM | MINT PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02407418 | MINT-ESCITALOPRAM | MINT PHARMACEUTICALS INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02309475 | MYLAN-ESCITALOPRAM | MYLAN PHARMACEUTICALS ULC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02309467 | MYLAN-ESCITALOPRAM | MYLAN PHARMACEUTICALS ULC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02364085 | SANDOZ ESCITALOPRAM | SANDOZ CANADA INCORPORATED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02364077 | SANDOZ ESCITALOPRAM | SANDOZ CANADA INCORPORATED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02385503 | SPC-ESCITALOPRAM | SUN PHARMA CANADA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02385481 | SPC-ESCITALOPRAM | SUN PHARMA CANADA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02318180 | TEVA-ESCITALOPRAM | TEVA CANADA LIMITED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Marketed |
| 02318202 | TEVA-ESCITALOPRAM | TEVA CANADA LIMITED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Marketed |
| 02313561 | ACT ESCITALOPRAM | TEVA CANADA LIMITED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Cancelled Post Market |
| 02313588 | ACT ESCITALOPRAM | TEVA CANADA LIMITED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Cancelled Post Market |
| 02313553 | ACT ESCITALOPRAM | TEVA CANADA LIMITED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 5 MG | Cancelled Pre Market |
| 02438496 | ESCITALOPRAM | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Cancelled Pre Market |
| 02438518 | ESCITALOPRAM | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Cancelled Pre Market |
| 02426331 | ESCITALOPRAM TABLETS | NORA PHARMA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Cancelled Post Market |
| 02426358 | ESCITALOPRAM TABLETS | NORA PHARMA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Cancelled Post Market |
| 02467380 | M-ESCITALOPRAM | MANTRA PHARMA INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Cancelled Pre Market |
| 02440296 | NAT-ESCITALOPRAM | NATCO PHARMA (CANADA) INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Cancelled Post Market |
| 02440318 | NAT-ESCITALOPRAM | NATCO PHARMA (CANADA) INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Cancelled Post Market |
| 02303949 | PMSC-ESCITALOPRAM | PHARMASCIENCE INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Dormant |
| 02303957 | PMSC-ESCITALOPRAM | PHARMASCIENCE INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 15 MG | Cancelled Pre Market |
| 02303965 | PMSC-ESCITALOPRAM | PHARMASCIENCE INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Dormant |
| 02303930 | PMSC-ESCITALOPRAM | PHARMASCIENCE INC | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 5 MG | Cancelled Pre Market |
| 02428849 | RIVA-ESCITALOPRAM | LABORATOIRE RIVA INC. | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 15 MG | Cancelled Pre Market |
| 02428830 | RIVA-ESCITALOPRAM | LABORATOIRE RIVA INC. | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 10 MG | Dormant |
| 02428822 | RIVA-ESCITALOPRAM | LABORATOIRE RIVA INC. | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 5 MG | Cancelled Pre Market |
| 02428857 | RIVA-ESCITALOPRAM | LABORATOIRE RIVA INC. | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG | Dormant |
| 02318199 | TEVA-ESCITALOPRAM | TEVA CANADA LIMITED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 15 MG | Cancelled Pre Market |
| 02318172 | TEVA-ESCITALOPRAM | TEVA CANADA LIMITED | Tablet | ESCITALOPRAM (ESCITALOPRAM OXALATE) 5 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6008 | 2004-12-24 | New Drug Submission (NDS) |